Multi‐organs perioperative <scp>immune‐related</scp> adverse events and postoperative bronchial anastomotic fistula in a patient receiving neoadjuvant immunotherapy with <scp>NSCLC</scp>-Reference-Cited by-同舟云学术

Multi‐organs perioperative immune‐related adverse events and postoperative bronchial anastomotic fistula in a patient receiving neoadjuvant immunotherapy with NSCLC

Published:2022-07-11 Issue:16 Volume:13 Page:2340-2345
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Xu Yuan¹,Lyu Xiaohong¹²,Qin Yingzhi¹,Ma Dongjie¹,Wang Mengzhao³,Shi Juhong³,Long Yun⁴,Tang Bo⁴,Liu Hongsheng¹^ORCID

Affiliation:

1. Department of Thoracic Surgery Peking Union Medical College Hospital, Chinese Academy of Medical Science Beijing China

2. Eight‐Year Program of Clinical Medicine Peking Union Medical College Beijing China

3. Department of Pulmonary and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

4. Department of Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14567

Reference27 articles.

1. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

2. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

3. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

4. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

5. Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Pleurisy as Immune-related Adverse Events of Neoadjuvant Nivolumab and Chemotherapy After Lobectomy;Haigan;2024-08-20

2. Perioperative immunotherapy for stage II-III non-small cell lung cancer: a meta-analysis base on randomized controlled trials;Frontiers in Oncology;2024-02-22

3. Remitting Seronegative Symmetrical Synovitis with Pitting Edema: A Case Report of an Immune-Related Adverse Event following Surgery;Case Reports in Oncology;2023-08-16

4. Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?;Thoracic Cancer;2023-04-24

5. Antineoplastics/methylprednisolone;Reactions Weekly;2022-09-10